Detalhe da pesquisa
1.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35325065
2.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33270816
3.
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling.
Cytotherapy
; 24(12): 1201-1210, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36109320
4.
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
Blood
; 132(22): 2351-2361, 2018 11 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30262660
5.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res
; 122(3): 479-488, 2018 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29208679
6.
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
Mol Ther
; 26(12): 2727-2737, 2018 12 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30309819
7.
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation
; 135(15): 1417-1428, 2017 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28209728
8.
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Am Heart J
; 201: 54-62, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29910056
9.
Regulation of Regenerative Medicine Products.
Adv Exp Med Biol
; 1098: 189-198, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30238372
10.
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.
Blood
; 125(26): 4103-13, 2015 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-25977584
11.
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.
Blood
; 123(24): 3750-9, 2014 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24782509
12.
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
Blood
; 123(25): 3895-905, 2014 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-24753538
13.
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.
Cytotherapy
; 18(2): 151-9, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26724220
14.
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
Blood
; 121(26): 5113-23, 2013 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-23610374
15.
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Blood
; 122(17): 2965-73, 2013 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24030379
16.
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
Cytotherapy
; 17(2): 140-51, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25455739
17.
Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
Cytotherapy
; 17(12): 1675-86, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26422657
18.
Inducible apoptosis as a safety switch for adoptive cell therapy.
N Engl J Med
; 365(18): 1673-83, 2011 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-22047558
19.
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
Invest New Drugs
; 32(2): 235-242, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23609828
20.
Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.
Cytotherapy
; 16(8): 1048-58, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24726657